Summary
This prediction ended on 20.09.16 with a price of €93.21. With a performance of -2.92%, the SELL prediction for Bayer AG by phonebroker was down slightly. phonebroker has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bayer AG | -5.146% | -5.146% | -45.120% | -41.720% |
iShares Core DAX® | 1.056% | 1.056% | 18.108% | 16.006% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% | 36.233% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% | 10.955% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% | 37.667% |
According to phonebroker what are the pros and cons of Bayer AG for the foreseeable future?
Pros
Cons
Comments by phonebroker for this prediction
In the thread Bayer AG diskutieren
Nicht kaufen
66 Milliarden für Monsanto. Einfach schlecht.
Für so viel Bargeld hat noch nie ein Konzern einen anderen übernommen.